SME Central
Home / Moved to Main Board / Sakar Healthcare

Sakar Healthcare: IPO, Share Price and Results Since Listing

Sakar Healthcare moved from NSE Emerge to the NSE main board on 11 April 2019. For Q2 FY2027 it reported revenue of INR 87.42 crore (+51.87% on a year earlier) and a profit after tax of INR 11.31 crore.

Key Facts

Moved to
NSE main board on 11 April 2019
Symbol
SAKAR
Latest close
INR 1,028.25 on 16 November 2026

Results Filed With NSE

Consolidated figures, INR crore. Change compares with the same period a year earlier.

PeriodRevenueChangeProfit after taxEPS (INR)Filed
Q2 FY202787.42+51.87%11.315.08main board23 October 2026
Q1 FY202772.97+38.37%10.284.62main board24 July 2026
Q4 FY202671.10+41.51%11.024.96main board12 May 2026
FY2026251.74+41.76%30.4813.70main board12 May 2026
Q3 FY202670.34–10.254.59main board5 February 2026
Q2 FY202657.56–4.542.03main board7 November 2025
Q1 FY202652.74–4.672.11main board25 July 2025
Q4 FY202550.24–5.762.66main board16 May 2025
FY2025177.58–17.507.97main board16 May 2025

Promoter Holding

Promoter holding has moved from 67.54% on 30 September 2021 to 51.70% on 30 September 2026 (-15.84 percentage points).

As ofPromotersPublic
30 September 202651.70%48.30%
30 June 202652.52%47.48%
31 March 202652.86%47.14%
31 December 202552.86%47.14%
30 September 202552.86%47.14%
30 June 202552.86%47.14%
31 March 202553.58%46.42%
31 December 202453.58%46.42%
30 September 202453.15%46.85%
30 June 202453.15%46.85%
31 March 202453.15%46.85%
31 December 202353.15%46.85%
30 September 202354.15%45.85%
1 September 202354.15%45.85%
30 June 202360.72%39.28%
31 March 202360.72%39.28%
24 February 202360.72%39.28%
31 December 202262.10%37.90%
30 September 202262.10%37.90%
8 July 202262.10%37.91%
30 June 202267.54%32.46%
31 March 202267.54%32.46%
31 December 202167.54%32.46%
30 September 202167.54%32.46%

Sources: NSE filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.